Please login to the form below

Not currently logged in
Email:
Password:

FDA approves Teva's Alzheimer's drug

The US Food and Drug Administration has approved Teva Pharmaceutical's application to sell a generic version of Pfizer's Alzheimer's drug Aricept

The US Food and Drug Administration (FDA) has approved Teva Pharmaceutical's application to sell a generic version of Pfizer's Alzheimer's drug Aricept (donepezil).

Teva said that it has already begun shipping the product, in 5mg and 10mg tablets.

Aricept has been the market leader among drugs that alleviate symptoms of Alzheimer's disease, such as memory problems, confusion and aggression.

Annual sales of the drug in the US are believed to be $2.3 bn.

Meanwhile Teva has declined to comment on media reports that its president and chief executive Shlomo Yanai flew to India several days ago to discuss potential collaborations with Indian pharmaceutical companies.

2nd June 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics